Veeva Announces Research Site Clinical Trial Management System
Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that ...
Veeva Systems (NYSE:VEEV) Unveils New CTMS for Efficient Clinical Trial Management
Veeva Systems (NYSE:VEEV) recently announced the launch of Veeva SiteVault CTMS, aiming to enhance clinical trial management efficiency, which coincides with a notable 10% share price increase over ...
pharmaphorum17h
EVERSANA joins with Veeva in push to 'pharmatise AI'
EVERSANA – pharmaphorum's parent company – said it has met the standard to join Veeva's partner programme and will now be ...
Analysts Set Veeva Systems Inc. (NYSE:VEEV) Price Target at $256.52
Shares of Veeva Systems Inc. (NYSE:VEEV – Get Free Report) have been assigned an average recommendation of “Moderate Buy” ...
Q1 EPS Estimates for Veeva Systems Boosted by Zacks Research
Research analysts at Zacks Research upped their Q1 2026 earnings per share estimates for Veeva Systems in a report released on Wednesday, March 26th. Zacks Research analyst R. Department now ...
Zacks Investment Research on MSN16h
5 Momentum Stocks to Buy for April Despite a Disappointing March
U.S. stocks suffered a blow, and the bull run halted in February. Wall Street also concluded a disappointing March. Market participants remained concerned about the Trump administration’s tariff and ...
pharmaphorum14h
RIF job losses are underway at HHS agencies; reports
Under Kennedy's plan, the FDA is set to bear the brunt of the job losses, with 3,500 workers due to be shed, while the CDC is ...